Prevalence, screening and postpartum control of gestational diabetes mellitus among the insurees of the health insurance company Dôvera

Authors: Daniela Adamkovičová 1;  Miriam Avramovová 3;  Silvia Dókušová 4;  Ivan Tkáč 2;  Beata Saal 1;  Martin Selvek 1;  Roman Mužik 1
Authors‘ workplace: DÔVERA zdravotná poisťovňa, a. s., Bratislava 1;  Excelentný tím pre výskum aterosklerózy (EXTASY), IV. interná klinika UPJŠ LF a UN LP, Košice 2;  Diabetologická ambulancia, Nemocnica Bory, Bratislava 3;  Diabetologické oddelenie, Národný endokrinologický a diabetologický ústav, Ľubochňa 4
Published in: Forum Diab 2023; 12(3): 77-84
Category: Original Article


Gestational diabetes mellitus (GDM) is one of the most common complications in pregnancy, seriously affecting the health of both mother and baby. The aim of the study was to find out the prevalence of GDM in its tribe, to map the screening of GDM during pregnancy and postpartum follow-up of patients with GDM from data of Dôvera Health Insurance Company (DZP). Between 2015 and 2022, the prevalence of GDM in the DZP among insurees averaged 12.5%, with a significant increase in the prevalence of GDM from 11.6% to 13.3% over the study period. The prevalence of GDM also increased significantly with the age of pregnant women. Significant differences in prevalence were also observed in different regions of Slovakia. For early diagnosis of GDM, screening by oral glucose tolerance test (oGTT) is performed in Slovakia, which is usually performed between 24–28 weeks of gestation. The analysis of DZP data shows that 58.9% of insured women were screened during pregnancy in the study period (2015–2022). Women with a history of GDM also have a higher risk of developing type 2 diabetes mellitus; therefore, glyc­emic control should be performed in such women no later than 6 months after delivery. Less than one-quarter of insured women (21.7%) in the GDM tribe had a postpartum check within 7 months of delivery, and 32.9% of insured women had their glycemia checked within a year after delivery.


gestational diabetes mellitus (GDM) – glycemic control – Health Insurance Company Dôvera – oral glucose tolerance tests (oGTT) – screening for gestational diabetes

  1. World Health Organization. Geneva: WHO; 2013. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013.
  2. ElSayed NA, Aleppo G, Aroda VR et al. [American Diabetes Association]. Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40. Dostupné z DOI: <>. 
  3. Giannakou K, Evangelou E, Yiallouros P et al. Risk factors for gestational diabetes: an umbrella review of meta-analyses of observational studies. PLoS One 2019; 14 (4), e0215372. Dostupné z DOI: <>.
  4. Petry CJ. Gestational diabetes: risk factors and recent advances in its genetics and treatment. Br J Nutr 2010; 104(6):775–787. Dostupné z DOI: <>.
  5. Pervjakova N, Moen GH, Borges MC et al. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet 2022; 31(19): 3377–3391. Dostupné z DOI: <http://dx,>.
  6. Plows JF, Stanley JL, Baker PN et al. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci 2018; 19(11): 3342. Dostupné z DOI: <>.
  7. Mumtaz M. Gestational diabetes mellitus. Malays J Med Sci 2000; 7(1): 4–9.
  8. Khan MA, Hashim MJ, King JK et al. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health 2020; 10(1): 107–111. Dostupné z DOI: <>.
  9. Saeedi M, Cao Y, Fadl H et al. Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysis. Diabetes Res Clin Pract 2021; 172: 108642. Dostupné z DOI: <>.
  10. IDF Diabetes Atlas, 2021. Dostupné z WWW: <>.
  11. Pankiewicz K, Szczerba E, Fijałkowska A et al. The Impact of Coexisting Gestational Diabetes Mellitus on the Course of Preeclampsia. Journal of Clinical Medicine. 2022; 11(21): 6390. Dostupné z DOI: <>.
  12. Avramovová M, Dókušová S, Dravecká I. Gestačný diabetes mellitus. Vestník MZ SR, 2023. Ročník 71. Dostupné z WWW: <>.
  13. Stotland NE, Caughey AB, Breed EM et al. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet 2014; 87(3): 220–226. Dostupné z DOI: <>.
  14. Bianco ME, Kuang A, Josefson JL et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study: newborn anthropometrics and childhood glucose metabolism. Diabetologia 2021; 64(3): 561–570. Dostupné z DOI: <–020–05331–0>.
  15. Egan AM, Enninga EAL, Alrahmani L et al. Recurrent Gestational Diabetes Mellitus: A Narrative Review and Single-Center Experience. J Clin Med 2021; 10(4): 569. Dostupné z DOI: <>.
  16. Vounzoulaki E, Khunti K, Abner SC et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369: m1361. Dostupné z DOI: <>.
  17. Baptiste-Roberts K, Barone BB, Gary TL et al. Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009; 122(3): 207–214.e4. Dostupné z DOI: <>.
  18. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 2019; 62(6): 905–914. Dostupné z DOI: <–019–4840–2>.
  19. ElSayed N, Aleppo G, Aroda V et al. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes – 2023. Diabetes Care 2023; 46 (Suppl 1): S254–S266. Dostupné z DOI: <>.
  20. NCZI. Starostlivosť o rodičku a novorodenca v Slovenskej republike 2021. [18–09–2023]. Dostupné z WWW: <>.
  21. ÚDZS. Oznámenie výšky podielu poistencov jednotlivých zdravotných poisťovní na celkovom počte poistencov na základe počtov poistencov k 1. 1. 2021 – Skutočný počet poistencov. [cit. 20–09–2023]. Dostupné z WWW: <>
  22. Rani PR, Begum J. Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand. J Clin Diagn Res 2016; 10(4): QE01–4. Dostupné z DOI: <>.
  23. Centers for Disease Control and Prevention. QuickStats: Percentage of Mothers with Gestational Diabetes,* by Maternal Age – National Vital Statistics System, United States, 2016 and 2021. [23–09–2023]. Dostupné z WWW: <>.
  24. ACOG. Gestational Diabetes Mellitus. Guideline Summary. [23–09–2023]. Dostupné z WWW: <>.
  25. Thompson D, Berger H, Feig D et al. [Canadian Diabetes Association Clinical Practice Guidelines Expert Committee]. Diabetes and pregnancy. J Diabetes 2013; 37(Suppl 1): S168–S183. Dostupné z DOI: <>.
  26. Megia A, Näf S, Herranz L et al. The usefulness of HbA1c in postpartum reclassification of gestational diabetes. BJOG 2012; 119(7): 891–894. Dostupné z DOI: <–0528.2012.03325.x>.
  27. Göbl, CS, Bozkurt, L, Yarragudi, R et al. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? Acta Diabetol 2014; 51(5): 715–722. Dostupné z DOI: <–014–0574–2>.
  28. Tovar A, Chasan-Taber L, Eggleston E et al. Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 2011; 8(6): A124.
  29. de Gennaro G, Bianchi C, Aragona M et al. Postpartum screening for type 2 diabetes mellitus in women with gestational diabetes: Is it really performed? Diabetes Res Clin Pract. 2020; 166: 108309. Dostupné z DOI: <>.
Diabetology Endocrinology Internal medicine
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account